Home > PS Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of TORRENT PHARMACEUTICALS is 9.52.

Share Price ₹3,159.4Nov 07,2024
Market Cap ₹106,914.1 Cr
Sales-TTM₹11,225.0 CrTTM-Consolidated Results
Price/Sales9.52xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of TORRENT PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹106,914.1 Cr] as on Nov 07,2024

(/) Sales [ ₹11,225.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 9.52x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '9.52 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of TORRENT PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of TORRENT PHARMACEUTICALS


PS Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/e ratio is 9.52x.

- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.75x.

- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 5.41x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 8.21x.

- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 4.2x.


How does TORRENT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
TORRENT PHARMACEUTICALS 11,225.09.52106,914.1
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.54429,841.0
CIPLA LTD26,512.04.79127,063.0
DR REDDYS LABORATORIES LTD30,084.93.57107,398.0
ZYDUS LIFESCIENCES LTD20,615.34.7597,866.3
DIVIS LABORATORIES LTD8,185.019.33158,179.0
MANKIND PHARMA LTD11,018.09.91109,234.0
LUPIN LTD20,797.14.6396,282.2
AUROBINDO PHARMA LTD29,718.42.6478,437.3
ABBOTT INDIA LTD6,066.19.9160,116.9
ALKEM LABORATORIES LTD12,731.75.3768,407.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TORRENT PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.64x
Max industry PS 19.33x
Median industry PS 5.37x
Average industry PS 7.54x



You may also like the below Video Courses